Biotech entity
All 1 tracked stories fall under one category: funding. Cepheid is most often covered alongside Merck & Co., which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Cepheid, all published on March 8, 2026.
Last mentioned: Mar 8, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: funding. Cepheid is most often covered alongside Merck & Co., which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Cepheid, all published on March 8, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Cepheid. Shared-story counts are live from our verified record — not editorial picks.
Elimination Target
Deadline for reaching the 90-70-90 vaccination, screening, and treatment goals.
$5.1M Grant Awarded
Major funding secured to scale screening and vaccination across the region.
Pilot Programs
Initial HPV self-collection pilots begin in select Pacific island nations.
WHO Global Strategy
WHO launches the global strategy to accelerate the elimination of cervical cancer.
A new $5.1 million grant has been awarded to accelerate cervical cancer elimination efforts across the Pacific region, focusing on HPV vaccination and advanced screening. The initiative aligns with the WHO's global strategy to eradicate the disease through the 90-70-90 targets by 2030.
Cepheid is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
